Jordi Riba and the Challenges of Studying Ayahuasca
Ayahuasca, the quintessential Amazonian psychedelic brew, harbors a complex pharmacology that Jordi Riba helped disentangle.
Articles by Mario de la Fuente Revenga, PharmD, PhD
The Legacy of Jordi Riba, a Pioneer of Modern Psychedelic Research
Jordi Riba Serrano PhD, a Spanish trailblazer in the resurgence of psychedelic science, passed away in August 2020 at the age of 51. His important contributions toward understanding the pharmacology of ayahuasca and other psychedelics will remain.
Quipazine: A Long-Standing Enigma in Psychedelic Research
The “psychedelic drug” label appears to define a clear-cut category. However, there are lesser-known research chemicals that depict more diffuse boundaries in this classification.